Potential colon cancer biomarker search using more than two performance measures in a multiple criteria optimization approach.

OBJECTIVE A new method using Multiple Criteria Optimization (MCO) proposed by our research group has shown evidence of being able to identify gene-based biomarkers for the detection of cancer using microarray data. Herein, we explore this method, considering more than two conflicting criteria for the MCO problem. Using this method would result in stronger outcomes when using different results from microarray analyses. It would also demonstrate that the method is suitable for carrying out meta-analysis. METHODS Statistical comparisons between normal and cancer tissues were performed using a colon cancer microarray database. The different comparisons were carried out with a Mann-Whitney non-parametric test using partial permutations of the data. An MCO problem was built using the different p-values obtained. The associated solution was the set of genes reaching the best compromises between the p-values under consideration that were located in the so-called efficient frontier. Data Envelopment Analysis (DEA) was used to find the efficient frontier of the MCO problem. The capacity of DEA was explored using different numbers of p-values (criteria) in the model. RESULTS The set of identified genes was consistent across the instances using different numbers of p-values in the DEA model, thereby providing evidence of the outcome stability of the proposed strategy. It was also observed that convergence to a larger number of potential biomarkers is faster with additional criteria, i.e., more p-values. CONCLUSION The MCO problem proposed for the cancer biomarker search using microarray data can be solved efficiently with DEA using more than two conflicting criteria. This approach can result in robust results when using different analyses of microarray data and, indeed, in a faster convergence to highly potential biomarkers.

[1]  Jin-Haeng Chung,et al.  DNA methylation profile during multistage progression of pulmonary adenocarcinomas , 2011, Virchows Archiv.

[2]  R. Silber,et al.  Molecular regulation of S100P in human lung adenocarcinomas. , 2008, International journal of molecular medicine.

[3]  T. Price,et al.  Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels , 2011, Clinical Proteomics.

[4]  H. Lenz,et al.  Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models , 2011, International journal of cancer.

[5]  K. Ho,et al.  A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis , 2007, Clinical Cancer Research.

[6]  L. Kiesel,et al.  miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness , 2010, Oncogene.

[7]  Xinyu Wu,et al.  Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer , 2011, PloS one.

[8]  J. Russo,et al.  S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. , 2000, International journal of oncology.

[9]  U. Alon,et al.  Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. , 2001, Cancer research.

[10]  Li Mao,et al.  Transcriptomic dissection of tongue squamous cell carcinoma , 2008, BMC Genomics.

[11]  R. Matusik,et al.  Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer , 2009, Molecular Cytogenetics.

[12]  Adrian R. Krainer,et al.  Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway* , 2010, Molecular & Cellular Proteomics.

[13]  Jae Yong Cho,et al.  Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer , 2011, PloS one.

[14]  M. Relling,et al.  A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity , 2011, Leukemia.

[15]  Jian-Jun Wei,et al.  Regulation of HMGA1 Expression by MicroRNA-296 Affects Prostate Cancer Growth and Invasion , 2010, Clinical Cancer Research.

[16]  W. Ruan,et al.  HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma , 2010, Journal of experimental & clinical cancer research : CR.

[17]  V. Abkevich,et al.  Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts , 2012, Genes, chromosomes & cancer.

[18]  José M. Castro,et al.  Identifying the Best Compromises between Multiple Performance Measures in Injection molding (im) using Data envelopment Analysis (DEA) , 2003, Trans. SDPS.

[19]  T. Haferlach,et al.  Molecular genetics in acute myeloid leukemia , 2010, Current opinion in oncology.

[20]  Antonio Reverter,et al.  A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer , 2011, BMC Systems Biology.

[21]  H. Kung,et al.  Targeting S100P Inhibits Colon Cancer Growth and Metastasis by Lentivirus-Mediated RNA Interference and Proteomic Analysis , 2011, Molecular medicine.

[22]  G. Zummo,et al.  Heat shock protein 10 and signal transduction: a “capsula eburnea” of carcinogenesis? , 2006, Cell stress & chaperones.

[23]  E. El-Omar,et al.  The Inflammatory Microenvironment in Colorectal Neoplasia , 2011, PloS one.

[24]  Anton Berns,et al.  Cancer: Gene expression in diagnosis , 2000, Nature.

[25]  L. Shkreta,et al.  Antagonistic Effects of the SRp30c Protein and Cryptic 5 ′ Splice Sites on the Alternative Splicing of the Apoptotic Regulator Bcl-x* , 2008, Journal of Biological Chemistry.

[26]  C. Johansson,et al.  Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism. , 2011, The Journal of general virology.

[27]  M. Roberti,et al.  Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival. , 2012, Human pathology.

[28]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Haferlach,et al.  Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia , 2011, TheScientificWorldJournal.

[30]  F. Bertucci,et al.  Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters , 2004, Oncogene.

[31]  Zhengxin Wang,et al.  Nuclear Transport Signals Control Cellular Localization and Function of Androgen Receptor Cofactor p44/WDR77 , 2011, PloS one.

[32]  P. Chieffi,et al.  High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene. , 2010, Cancer research.

[33]  M. Tainsky,et al.  Genomic and proteomic biomarkers for cancer: a multitude of opportunities. , 2009, Biochimica et biophysica acta.

[34]  W. Guo,et al.  Genome‐wide copy number analyses identified novel cancer genes in hepatocellular carcinoma , 2011, Hepatology.

[35]  N. Lemoine,et al.  Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. , 2005, The American journal of pathology.

[36]  J. Manley,et al.  Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. , 2010, Cancer research.

[37]  N. Probst-Hensch,et al.  Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. , 2010, Human pathology.

[38]  J. Plachy,et al.  The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells , 2010, Cellular and Molecular Life Sciences.